Newer Hemostatic Agents Used in the Practice of Dermatologic Surgery [PDF]
Dermatology Research and Practice, 2013 Minor postoperative bleeding is the most common complication of cutaneous surgery. Because of the commonality of this complication, hemostasis is an important concept to address when considering dermatologic procedures.
Jill Henley, Jerry D. Brewer
doaj +3 more sources
Novel antiangiogenic agents in dermatology [PDF]
Archives of Biochemistry and Biophysics, 2011 Because angiogenesis underlies the pathogenesis of numerous conditions (cancer, psoriasis, macular degeneration), there is a pressing need for continued investigations into angiogenic signaling and potential drug targets. Antiangiogenic agents can be classified as either direct or indirect.
Ricardo L. Berrios +2 more
openaire +4 more sources
Achieving hemostasis in dermatology-Part II: Topical hemostatic agents
Indian Dermatology Online Journal, 2013 Bleeding is a common occurrence during any dermatologic surgery that disrupts blood vessels. The complications of excess bleeding can include delayed wound healing, hematoma formation, infection, dehiscence, and necrosis.
Jaimie B Glick +2 more
doaj +2 more sources
A review of non-pharmacologic approaches to enhance the patient experience in dermatologic surgery [PDF]
Dermatology Online Journal, 2020 Efforts to increase patient comfort by minimizing pain and anxiety have been shown to improve clinical outcomes, reduce pain thresholds, decrease analgesic requirements and complication risk, strengthen the physician-patient relationship, and increase ...
Alkousakis, Theodore +3 more
core +2 more sources
A Closer Look at the Dermatological Profile of GLP-1 Agonists [PDF]
DiseasesBackground/objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used in treating type 2 diabetes and obesity, offering established metabolic and cardiovascular benefits.
Calista Persson +2 more
doaj +2 more sources
Intralesional agents in dermatology: Pros and cons
Journal of Cutaneous and Aesthetic Surgery, 2021 Since introduced in 1961, intralesional (IL) agent has become an essential part of the dermatological practice. The term IL referred to the direct delivery of agent percutaneously into skin lesions. This therapeutic approach is relatively safe, easy to perform and applicable for a broad range of dermatological conditions.
Bansi Hirapara +7 more
openaire +4 more sources
Serpentine Supravenous Hyperpigmentation, a Phenomenon Following the Administration of Chemotherapeutic Agents: A Systematic Review [PDF]
Health Science ReportsBackground Serpentine supravenous hyperpigmentation (SSH) is known as a phenomenon occurring during the infusion of chemotherapy agents in the underlying veins.
Hanieh Radkhah +2 more
doaj +2 more sources
Dermatologic Therapy, 2020 The ongoing COVID‐19 epidemic has brought to the fore many concerns related to use of immunosuppressive agents (ISAs) in dermatology. While it is unclear whether the patients on ISAs for skin conditions are more prone to develop COVID‐19, and what impact
A. Khurana, Snigdha Saxena
semanticscholar +2 more sources
Secukinumab Leading to Rapid Improvement in Pyogenic Arthritis, Acne, Pyoderma Gangrenosum, and Hidradenitis Suppurativa (PAPASH) Syndrome: A Case Report and Review of Treatment Modalities for PAPASH Patients [PDF]
Case Reports in RheumatologyPAPASH syndrome, a rare autoinflammatory condition characterized by pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa, presents significant treatment challenges due to its rarity and complex multisystem involvement.
Inga N. Shevtsova +4 more
doaj +2 more sources
Integrating MAPK pathway inhibition into standard-of-care therapy for pediatric low-grade glioma [PDF]
Frontiers in OncologyPediatric low-grade gliomas (pLGG) are a group of tumors largely driven by alterations in a single genetic pathway, known as the RAS-RAF-mitogen-activated protein kinase (MAPK) pathway.
Erin E. Crotty +3 more
doaj +2 more sources